We are live on ! Find out more
CWP

Concord Wealth Partners Portfolio holdings

AUM $873M
1-Year Est. Return 24.02%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+24.02%
3 Year Est. Return
+66.02%
5 Year Est. Return
+59.32%
10 Year Est. Return
AUM
$409M
AUM Growth
+$164M
Cap. Flow
+$154M
Cap. Flow %
37.57%
Top 10 Hldgs %
50.47%
Holding
1,375
New
463
Increased
640
Reduced
28
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 8.68%
2 Financials 4.92%
3 Healthcare 3.9%
4 Consumer Discretionary 3.33%
5 Industrials 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPL
401
PPL Corp
PPL
$26.5B
$66K 0.02%
2,195
+126
+6% +$3.64K
IYE icon
402
iShares US Energy ETF
IYE
$1.74B
$65K 0.02%
+2,157
New +$66.4K
PSX icon
403
Phillips 66
PSX
$82.7B
$65K 0.02%
902
+341
+61% +$25.8K
SUB icon
404
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$65K 0.02%
+604
New +$64.9K
VAW icon
405
Vanguard Materials ETF
VAW
$2.99B
$65K 0.02%
332
+156
+89% +$29.4K
BIIB icon
406
Biogen
BIIB
$29.8B
$64K 0.02%
265
+241
+1,004% +$62K
GIS icon
407
General Mills
GIS
$19.2B
$64K 0.02%
954
+70
+8% +$4.45K
QRVO icon
408
Qorvo
QRVO
$7.89B
$64K 0.02%
408
+384
+1,600% +$61K
RBLX icon
409
Roblox
RBLX
$26.2B
$64K 0.02%
619
SDG icon
410
iShares MSCI Global Sustainable Development Goals ETF
SDG
$171M
$64K 0.02%
700
TROW icon
411
T. Rowe Price
TROW
$24.3B
$64K 0.02%
328
+318
+3,180% +$64.6K
EW icon
412
Edwards Lifesciences
EW
$51.1B
$62K 0.02%
480
+202
+73% +$23.6K
L icon
413
Loews
L
$23.9B
$62K 0.02%
1,080
+947
+712% +$53.7K
UGI icon
414
UGI
UGI
$7.78B
$62K 0.02%
1,352
+78
+6% +$3.47K
UTHR icon
415
United Therapeutics
UTHR
$25.7B
$62K 0.02%
287
+242
+538% +$47.5K
ALK icon
416
Alaska Air
ALK
$5.6B
$61K 0.01%
1,177
+596
+103% +$32.3K
BA icon
417
Boeing
BA
$185B
$61K 0.01%
304
+98
+48% +$20.7K
DIA icon
418
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.7B
$61K 0.01%
168
+38
+29% +$13.5K
IWD icon
419
iShares Russell 1000 Value ETF
IWD
$82.6B
$61K 0.01%
364
+352
+2,933% +$57.7K
SLV icon
420
iShares Silver Trust
SLV
$28B
$61K 0.01%
2,828
+2,225
+369% +$48.1K
WSBC icon
421
WesBanco
WSBC
$4.01B
$61K 0.01%
1,745
CRSP icon
422
CRISPR Therapeutics
CRSP
$4.88B
$60K 0.01%
796
+585
+277% +$51.1K
FDN icon
423
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.33B
$60K 0.01%
266
+201
+309% +$47.6K
ICLN icon
424
iShares Global Clean Energy ETF
ICLN
$2.35B
$60K 0.01%
2,819
+384
+16% +$8.83K
KMX icon
425
CarMax
KMX
$8.29B
$60K 0.01%
457
+82
+22% +$11.5K

Similar funds

Concord Wealth Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Concord Wealth Partners held 1,375 positions worth $409M, up 67% from $244M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Concord Wealth Partners deployed $154M of net new capital in Q4 2021, opening 463 new positions and adding to 640 existing holdings. Its largest new stake was Schwab Intermediately-Term US Treasury ETF: 394,824 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P Kensho New Economies Composite ETF, an estimated $1.87M trimmed.

  • Concord Wealth Partners's largest Q4 2021 buy was Schwab Intermediately-Term US Treasury ETF: 394,824 shares worth $11.1M.
  • Concord Wealth Partners added most to State Street SPDR Portfolio Developed World ex-US ETF in Q4 2021, an estimated $6.46M increase.
  • Concord Wealth Partners's biggest Q4 2021 reduction was State Street SPDR S&P Kensho New Economies Composite ETF, cutting an estimated $1.87M.
  • Concord Wealth Partners fully exited Transocean in Q4 2021, selling an estimated $55K.
  • Concord Wealth Partners's ten largest holdings make up 50% of its $409M portfolio in Q4 2021.
  • Concord Wealth Partners opened 463 new positions and closed 33 in Q4 2021.
  • Concord Wealth Partners's portfolio value rose 67% quarter-over-quarter to $409M.

Based on Concord Wealth Partners's 13F filing for Q4 2021, filed 21 Jan 2022.